Your browser doesn't support javascript.
loading
An All-in-One Nanomedicine Consisting of CRISPR-Cas9 and an Autoantigen Peptide for Restoring Specific Immune Tolerance.
Luo, Ying-Li; Liang, Li-Fang; Gan, Yun-Jiu; Liu, Jing; Zhang, Yue; Fan, Ya-Nan; Zhao, Gui; Czarna, Anna; Lu, Zi-Dong; Du, Xiao-Jiao; Shen, Song; Xu, Cong-Fei; Lian, Zhe-Xiong; Wang, Jun.
Afiliação
  • Luo YL; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
  • Liang LF; School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, P. R. China.
  • Gan YJ; Hefei National Laboratory for Physical Sciences at the Microscale, School of Life Sciences, University of Science and Technology of China, Hefei 230027, P. R. China.
  • Liu J; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
  • Zhang Y; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
  • Fan YN; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
  • Zhao G; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
  • Czarna A; Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
  • Lu ZD; Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
  • Du XJ; Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
  • Shen S; Key Laboratory of Biomedical Materials and Engineering of the Ministry of Education, South China University of Technology, Guangzhou 510006, P. R. China.
  • Xu CF; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
  • Lian ZX; Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.
  • Wang J; Institutes for Life Sciences, School of Medicine, South China University of Technology, Guangzhou 510006, P. R. China.
ACS Appl Mater Interfaces ; 12(43): 48259-48271, 2020 Oct 28.
Article em En | MEDLINE | ID: mdl-33070614
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Autoantígenos / Nanomedicina / Sistemas CRISPR-Cas Limite: Animals / Humans Idioma: En Revista: ACS Appl Mater Interfaces Assunto da revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos / Autoantígenos / Nanomedicina / Sistemas CRISPR-Cas Limite: Animals / Humans Idioma: En Revista: ACS Appl Mater Interfaces Assunto da revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos